INTREPID Alliance Launches Antiviral Toolbox to Support Global Research Community
Open-access resource includes Registry of Antiviral Compound Libraries to help catalyze drug…
Fueling Discovery: Misophonia Research Fund Launches New Team Science Award, Expands 2026 Funding Opportunities, and Announces Latest Grantee Cohort
CHICAGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Misophonia Research Fund (MRF),…
Springer Nature honours Indian editors at Journal Development Symposium 2025. Brings Together Leading Editors and Publishing Experts to Shape the Future of Research Integrity and AI in Scholarly Communication
NEW DELHI, Oct. 31, 2025 /PRNewswire/ -- The day long Journal Development…
ITALY, ECOMONDO 2025, GLOBAL RESEARCH AND INNOVATION HUB
From 4th to 7th November, 1.700 exhibiting brands, 350 buyers from 66 countries, 30…
HTX Research Report Spotlights SunPerp as the Breakout Player in the 2025 Perpetual DEX Boom
PANAMA CITY, Oct. 27, 2025 /PRNewswire/ -- HTX Research, the dedicated research…
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM),…
New Benevity Impact Labs Research Reveals a Confidence Gap Among Global Grantmakers
Newly released Grants Confidence Gap Report uncovers the hidden barriers to effective…
World’s Leading Nutrition Researchers Discuss Future Lines of Research on Nuts and Dried Fruit at NUTS 2025
REUS, Spain, Oct. 22, 2025 /PRNewswire/ -- Leading health researchers from around…
ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025
Study data also showed prolonged progression-free survival with 177Lu-edotreotide compared to everolimus…
TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research
With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces…
